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Abstract: This is a systematic review of cases with Lemierre’s syndrome (LS) in the past 5 
years. LS is characterized by sepsis often evolving after a sore throat or tonsillitis and then com-
plicated by various septic emboli and thrombosis of the internal jugular vein. Symptoms include 
sepsis, pain, and/or swelling in the throat or neck, as well as respiratory symptoms. Laboratory 
findings show elevated infectious parameters and radiological findings show thrombosis of the 
internal jugular vein and emboli in the lungs or other organs. The syndrome is often associated 
with an infection with Fusobacterium necrophorum. We found a total of 137 cases of LS, of 
which 47 were infected with F. necrophorum and others with Staphylococcus and Streptococ-
cus. Complications of this rare but severe disease included osteomyelitis, meningitis, and acute 
respiratory distress syndrome. Mortality was extremely high in the pre-antibiotic era but has 
diminished with the advent of antibiotics. This review showed a mortality rate of only 2% of 
which none of the cases involved fusobacteria. Duration of treatment varied; a 4–6-week course 
of carbapenem or piperacillin/tazobactam in combination with metronidazole was optimum. 
Other treatment options included anticoagulants in 46% of cases, which is unwarrantedly high, 
as to date, no evidence of the positive effects of anticoagulants in LS exists. Only two cases 
had ligation of the internal jugular vein performed. This review confirms the rare, but severe 
aspects of LS. Mortality from LS in this day and age appears to be low, however the syndrome 
is difficult to recognize, and still requires the full attention of the clinician.
Keywords: Lemierre’s syndrome, fusobacteria, postanginal sepsis
Definition
Lemierre’s syndrome (LS) takes its name after the French bacteriologist André-Alfred 
Lemierre, who first described the syndrome in 1936.1 The syndrome is defined by a 
pharyngeal infection, complicated by septicemia and internal jugular vein thrombo-
sis followed by septic emboli. Due to the introduction of antibiotics, LS has aptly 
been referred to as “the forgotten disease”. The most commonly involved bacteria is 
Fusobacterium necrophorum but other bacteria such as fusobacteria, Streptococcus, 
Staphylococcus, and Enterococcus are commonly found in cultures.2 Other bacteria, 
such as Klebsiella Pneumoniae have rarely been described in middle-aged persons 
with newly diagnosed type 2 diabetes.3
Patients with LS present with a prolonged sore throat, neck pain, and often with 
fever.4 Patients are often young (age 16–30 years) and otherwise healthy, but appear 
acutely ill with tachycardia, tachypnea, hypotension, and a poor saturation (often 
<95%).2,3,5,6 Laboratory findings showed leukocytosis with dominating neutrocytosis 
and elevated C-reactive protein as well as signs of organ failure, such as elevated 
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liver enzymes. Imaging of the internal jugular vein showed 
thrombosis.2,5
Complications to this severe syndrome include a mortality 
rate as high as 10%,3 especially when antibiotic treatment is 
delayed.7 Other less severe complications include metastatic 
infections in joints, internal organs (often lungs), and/or 
the brain.6
Fusobacterium necrophorum has a reputation for being 
resistant to penicillin, thus the drugs of choice have primar-
ily been β-lactamase-resistant β-lactams, such as piperacil-
lin–tazobactam, even though many strains are sensitive to 
penicillin in combination with metronidazole.4,7
The syndrome remains difficult to diagnose due to its low 
incidence and absence of pathognomonic symptoms. Thus, 
symptoms mimic other common diseases. Botros et al8 have 
described this dilemma in an excellent manner.
The present study is a review of the publications in the 
past 5 years concerning LS. A PubMed search was carried out 
using the MeSH terms “Lemierre Syndrome/classification”, 
“Lemierre Syndrome/diagnosis”, “Lemierre Syndrome/etiol-
ogy”, and “Lemierre Syndrome/therapy”. Inclusion criteria 
were: studies published in English language, dealt with human 
subjects, and apublication date within the last 5 years. The 
search elicited 121 papers, of which the abstracts were read, 
and 18 papers were excluded as they did not concern LS. 
The full text of 103 papers was read, after which seven were 
excluded, since they did not include any data on patients/cases. 
A total of 137 cases were included for this review (Figure 1).
Diagnosis
A definite diagnosis of LS should be made based on the 
following findings:7,9
1) a recent pharyngeal illness,
2) complicated by septic emboli,
3) as well as either thrombosis of the internal jugular vein 
or findings of F. necrophorum in blood cultures.
Records identified through
database searching
(n=121)
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Records after duplicates removed
(n=121)
Records screened
(n=121)
Full-text articles assessed
for eligibility
(n=103)
Studies included in
qualitative synthesis
(n=96)
Full-text articles excluded,
with reasons
(n=7)
Records excluded
(n=18)
Additional records identified
through other sources
(n=0)
Figure 1 Lemierre’s syndrome review: study inclusion and exclusion flow diagram.
Notes: Figure created using PRISMA 2009 flow diagram software from Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009). Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097 doi: 10.1371/journal.pmed.1000097. For more information, visit www.prisma-statement.org.94
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Clinical
This review yielded at total number of 137 cases2,3,5,6,8,10–90 
including both case reports and minor reviews. The major 
clinical characteristics of LS are reported in Table 1. Twenty-
four percent of the cases were presented with a complaint in 
the pharyngeal area (tonsillitis, pharyngitis, common sore 
throat), whereas a few came with an initial complaint of a 
swelling of the neck,37,61,64–66,73,82 due to either the thrombus 
itself or an abscess located in the neck region. Only eleven 
cases were described with initial difficulties in the dental 
region,6,16,18,42,46 the otogenic region,18,19,68,77 or the central 
nervous system.29,45 Atypical presentations included seizures90 
and blindness.60,63 Half the cases were presented with sepsis at 
their first evaluation in the hospital, and at least 17 cases were 
intubated (not reported in all articles), underlining the severity 
of LS. Interestingly, the location of the primary infection is an 
important prognostic factor: infection in the oropharyngeal 
location (compared to other sites) was associated with a higher 
risk of longer intensive care unit stays due to complications 
such as respiratory problems.18 At least 37 of the cases in 
this review were not in the age group usually associated with 
LS, rather they were older than 30 years or younger than 
15 years. Eleven were children younger than 15 years, who 
presented with a variety of symptoms, including pharyngitis59 
and/or pneumonia43 and also more severe symptoms such as 
meningitis45 or febrile seizures.58 None of the children in this 
review died. In the older age group too, common complaints 
such as pneumonia40 dominated, but also here more severe 
symptoms/illnesses were seen, such as multiple emboli.38 It 
had previously been found that other diseases underlie LS in 
these older patients, such as diabetes or cancer.91
The overall mortality was 2%, death was reported only 
in two of 137 cases. This is considerably less than previously 
reported.91 Briefly, no fusobacteria were cultured in the fol-
lowing two cases: 1) a diabetic patient with tonsillitis and 
peritonsillar abscess (K. pneumoniae positive culture)3 and 
2) a 79-year old with tonsillitis and multiple septic emboli 
in lungs, liver, heart, kidney, and joints (Streptococcus angi-
nosus positive culture).38 In a previous study, we presented 
morbidity and mortality in patients with positive cultures in 
blood, sputum, or pleural effusion with fusobacteria versus 
Staphylococcus aureus and showed that infections with 
fusobacteria were associated with a significantly lower 1-year 
mortality.92 Only one patient in the fusobacteria group in that 
study had LS,49 but generally mortality in the fusobacteria 
group was due to comorbidity and not due to severity of the 
infection itself. It could be speculated that publication bias 
plays an important role when trying to estimate the mortality 
in this rare syndrome. It could go both ways: fatal cases with 
a lesser likelihood to be published due to the simple fact that 
these cases could be missed and not diagnosed at all; or fatal 
cases could have a higher likelihood to be published due to 
the interest in why these cases become fatal.
Microbiological
In this review, 96 cases reported a causative microbiological 
agent; the majority of the cases were infections with F. nec-
rophorum (41), Fusobacterium nucleatum (6), and unspecified 
fusobacteria (3), others were infections with microbiological 
agents such as Streptococcus (17), including methicillin-
resistant S. aureus, and S. aureus (six cases) (Figure 2). These 
findings suggest that F. necrophorum is still the major micro-
biological agent in LS, but it could also be due to reporting 
bias, as clinicians and/or editors only approve “the forgotten 
disease” when fusobacteria is present in relevant cultures. 
Fusobacterium necrophorum (and other fusobacteria) is an 
obligate anaerobic bacterium and is notoriously difficult to 
culture, requiring a longer incubation period than other bac-
teria.92 A large proportion of the cases did not report a micro-
biological agent (n=40). As with other bacteria, cultures can 
be false negative if antibiotics are administered before sample 
collection. Whether the cases without a positive culture of F. 
necrophorum (or other fusobacteria) are true cases of LS is 
debatable. In the review by Riordan,9 it was suggested that F. 
necrophorum is in fact present in all patients with LS but goes 
undetected due to various circumstances and that the bacteria 
detected would be unable to cause LS on its own. However, 
this quite stern conclusion has not been accepted as a common 
rule in the clinical community, and so far a clinical diagnosis of 
LS is still valid if the bacteria either go undetected or turn out 
to be Streptococcus or some other known pathogenic bacteria.
Imaging
Concerning the diagnosis of the infectious thrombosis, the 
optimal imaging tool is still debated. Ultrasonography is a 
radiation-free and easily available bedside tool, but it has 
the disadvantage of being less sensitive for recently formed 
Table 1 Common clinical characteristics of Lemierre’s syndrome
Symptom Percentage
Septic emboli 100
Thrombosis of the internal jugular vein 84
Sepsis 50
A sore throat 24
Swelling of the neck 5
CNS affection 3.6
Abbreviation: CNS, central nervous system.
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thrombosis material, with a lesser echogenicity, as well as 
difficulties in the deeper tissue areas around the clavicle and 
mandible.93 Magnetic resonance imaging (MRI) is an excel-
lent method for visualizing all anatomic structures as well as 
the thrombosis and/or septic emboli. However, MRI is expen-
sive and usually not readily available. Computed tomography 
(CT) scans are cheaper and available in most hospitals, but it 
involves radiation exposure. In this review, the vast majority 
of cases (95%) with thrombophlebitis of the internal jugular 
vein were diagnosed by CT scans. Ultrasonography was used 
by the remaining cases, but none used MRI.
In total, ten cases (7%) had no or unknown thrombus 
during their disease. The majority of cases (84%) had throm-
bosis of the internal jugular vein, while a few (9%) cases 
had thrombosis of other veins, such as the facial vein, sinus 
transversus, or vena ophthalmicus.47,60
A larger proportion of cases (71 cases) had septic emboli 
in the lungs, but septic emboli were also seen in other organs, 
such as the liver,12,38,87 spleen,81 joints,38,70 heart,38 and the 
central nervous system,29,31 even though in smaller numbers.
Management
Antibiotics
All but a few rare cases received antibiotic treatment dur-
ing their hospital stay. Multiple different regimens of the 
antibiotic of choice were used. Resistance to penicillin was 
not found at an increased frequency. However, carbapenem 
and piperacillin/tazobactam were commonly used, either as 
monotherapy or in combination with metronidazole, and 
98% of the cases (mortality n=2) were treated successfully. 
The mean duration of antibiotic treatment was 4 weeks, but it 
ranged from 10 days to 8 weeks. The reason for the choice of 
a particular duration was not explained in any of the included 
papers. Riordan9 highlights the features of metronidazole 
and also recommends it as monotherapy, which was not 
seen in any of the cases in this review. He especially praises 
metronidazole for its profound activity against all strains of 
Fusobacterium spp., its good penetration within the tissue, 
and its good oral availability. Regarding treatment duration, 
Riordan9 and others have, similar to this review, found a wide 
range of treatment duration; however, it seems that there is no 
justified reason for prolonged intravenous treatment in cases 
of LS, and thus, if the patient responds well to treatment, he/
she could be switched to oral treatment after the first 2 weeks 
of intravenous antibiotics.9
Anticoagulation
Anticoagulation is still a controversial issue, with no proper 
studies carried out on the issue. In this review, we found that 
87 cases (64%) received anticoagulation treatment, often with 
low-molecular-weight heparin. Treatment duration varied 
between 2 weeks and 6 months. A few (n=2) patients suffered 
from side effects (hemorrhage or disseminated intravascular 
coagulation) and were treated accordingly without serious 
adverse effects.32,87 In the review by Riordan and also previous 
reviews, the frequency of patients treated with anticoagulants 
was 21%–23%. The high prevalence in this study might be 
due to the widespread, unconfirmed hypothesis regarding the 
positive effects of anticoagulants, which seem to have gained 
a favorable position in the clinic. Also, within this review, we 
have not subdivided the patients receiving anticoagulation 
treatment regarding thrombosis solely in the jugular vein 
and thrombosis involving sinus cavernosus. The latter is a 
more severe situation and thus requires a more aggressive 
treatment strategy.
Other forms of treatment
A substantial number of cases (n=17) had abscesses in various 
anatomical locations: lungs, liver, epidura, and neck. Gener-
ally, accessible abscesses were treated by drainage. Rarely, 
other surgical procedures were performed: tooth extraction,84 
craniotomy,69 and ligation of the occluded vein,18,65,68 in order 
to prevent further septic emboli. Common for these cases 
30 %
4 %
4 %
2 %
2 %
2 %
8 %
10 %5 %
33 %
Fusobacterium necrophorum Fusobacterium nucleatum
Klebsiella pneumoniae
Pseudomonas aeruginosa
MRSA
Not found
Fusobacteria spp.
Streptococci
Stapholycoccus aureus
Other bacteria
Figure 2 Distribution of bacterial agent.
Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus.
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were severe illness, and all other treatment modalities were 
already initiated, ligation seems to be reserved exclusively 
for extremely ill patients.
Conclusion
Given that we identified only 30 case reports from 2012, 
27 from 2014, and ten from 2015, it does not seem that the 
incidence of LS is increasing. However, these are specula-
tions, and evidently publication bias is unavoidable, and 
the “market” might be saturated with case reports on the 
subject. The syndrome still deserves the name “the forgot-
ten disease”, and most fusobacterial infections are not LS. 
A fatal outcome is rare.
Diagnosing LS still requires thorough clinical examination 
and awareness of the association between current acute medical 
illness and a recent pharyngeal infection; yet, there is a need 
for studies on the diagnostic outcomes when LS is suspected.
Furthermore, early collection of blood samples and 
microbiology cultures in severely ill patients are required to 
establish a microbiological diagnosis. Symptoms of possible 
thrombosis need evaluation by an early CT scan or ultra-
sonography. The former has a better diagnostic capability, 
including intrathoracic vessels and septic emboli.
Treatment is efficacious and follows the general principles: 
systemic antibiotics, drainage of abscesses, and, perhaps, 
anticoagulation. Antibiotic treatment is crucial and should 
be corrected according to microbiological results on drug 
resistance. Penicillin, carbapenem, or piperacillin/tazobactam 
– often in combination with metronidazole – is efficacious. 
The optimal duration of treatment is not established, but 
2 weeks of intravenous antibiotics with a total of 4–6 weeks 
seems sufficient. However, duration needs individualization 
according to disease severity and follow-up results, including 
imaging and serological inflammatory markers.
Based on the current evidence, it is still unknown 
whether anticoagulation therapy is mandatory. There were 
no apparent differences in mortality or course between the 
64% cases treated with anticoagulants versus the 36% who 
were not. However, confounding by indication is most likely. 
Unfortunately, no randomized studies on this controversy 
are available.
Overall, LS is characterized by the absence of large-scale 
studies, but hopefully the future will witness a pragmatic 
multicenter approach to address the various controversies 
of this intriguing disease.
Disclosure
The authors report no conflicts of interest in this work.
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